| Location: | Germany |
| Job Type: | Full-Time |
| Employer: | Doccla |
NHS trusts need a lot of technology, but they face complex, structural challenges when it comes to procurement, and these tend to work against smaller companies and innovation. The Highland Marketing advisory board met recently to discuss the issues and the role of marketing.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, today announced FDA clearance allowing the activation of SedLine® Brain Function Monitoring, Regional Oximetry (O3®), and CO2 measurements in Philips Patient Monitors - IntelliVue MX750 and MX850.
Today, most drug discovery is carried out by human chemists who rely on their knowledge and experience to select and synthesize the right molecules needed to become the safe and efficient medicines we depend on.
Nurses and doctors at South Tees Hospitals NHS Foundation Trust have remarked on substantial time savings and safer ways of working, just hours after the go-live of a new digital noting solution.
The deployment of Miya Noting is an important part of the trust's electronic patient record programme, which is responding to urgent priorities faced by clinical teams through the Alcidion modular EPR, Miya Precision.
Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated to supporting environmental, water, wastewater and other analytical testing laboratories that protect health and safety.
Heart failure is an umbrella term for when the heart is unable to pump blood around the body properly. Current ways of classifying heart failure do not accurately predict how the disease is likely to progress.
The process they used could also speed the discovery of other antibiotics to treat many other challenging bacteria.
Siemens Healthineers is building a new factory in Forchheim for the cultivation of crystals for semiconductor production. The total investment amounts to 80 million euros. The new factory is expected to create 100 new jobs. The existing production facility in Japan is reaching its capacity limits. The crystals are used as detector material for the latest generation of CT scanners.